13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q2 2016. See the latest, Q2 2026 →
Reported value
$386.87B
+1.8% on the quarter before
Positions
2,073
210 new · 238 sold out
Top 10
17.1%
of the value
Est. gain
+$10.14B
on stocks held all quarter
Est. return
+2.9%
on those stocks since Q1 2016
Positions as of Jun 30, 2016, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 30% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2016. Striped tiles are options.
Largest buys
Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Mckesson Corp~$721.8MAdded · 0.5% → 0.7%+3,867,243 shares
- Allergan Plc~$718.9MAdded · 1.5% → 1.4%+3,110,863 shares
- Dow Chem Co~$641.2MAdded · 0.2% → 0.4%+12,899,739 shares
- Intercontinental Exchange In~$637.6MAdded · 0.2% → 0.4%+2,491,027 shares
- Boeing Co~$633.3MAdded · 0.0% → 0.2%+4,876,413 shares
- Pepsico Inc~$540.3MAdded · 0.6% → 0.7%+5,100,103 shares
- Costco Whsl Corp New~$526.6MAdded · 0.6% → 0.7%+3,352,998 shares
- L Brands Inc~$473.5MAdded · 0.1% → 0.2%+7,053,920 shares
- S&P Global Inc~$448.9MNew · 0.0% → 0.1%+4,185,291 shares
- Suncor Energy Inc New~$442.4MAdded · 0.3% → 0.4%+15,967,556 shares
Largest sells
Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- United Technologies Corp~$835.9MCut · 0.5% → 0.3%−8,151,420 shares
- General Electric Co~$656.0MCut · 0.6% → 0.4%−20,838,218 shares
- Raytheon Co~$560.5MCut · 0.3% → 0.2%−4,123,177 shares
- Baxter Intl Inc~$551.9MCut · 0.4% → 0.3%−12,205,073 shares
- Bristol Myers Squibb Co~$537.8MCut · 2.3% → 2.5%−7,312,300 shares
- Praxair Inc~$515.1MCut · 0.4% → 0.2%−4,583,132 shares
- Becton Dickinson & Co~$485.8MCut · 0.4% → 0.3%−2,864,271 shares
- Cvs Health Corp~$441.3MCut · 0.8% → 0.6%−4,608,855 shares
- American Express Co~$436.3MCut · 0.4% → 0.3%−7,180,135 shares
- Goldman Sachs~$396.0MCut · 0.3% → 0.1%−2,664,959 shares
Holdings
As of Jun 30, 2016. Changes are in shares against Mar 31, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck & Co IncCOM · shares −2.3% · price +8.9% | 2.6% | $10.14B | +$826.9M | ||||||||
| Bristol Myers Squibb CoCOM · shares −5.3% · price +15.1% | 2.5% | $9.53B | +$1.25B | ||||||||
| Unitedhealth Group IncCOM · shares −0.1% · price +9.5% | 1.9% | $7.43B | +$647.6M | ||||||||
| MicrosoftCOM · shares −4.9% · price −7.4% | 1.9% | $7.32B | −$580.4M | ||||||||
| Medtronic PlcSHS · shares +2.8% · price +15.7% | 1.7% | $6.59B | +$869.7M | ||||||||
| Wells Fargo & Co NewCOM · shares −1.4% · price −2.1% | 1.6% | $6.13B | −$133.3M | ||||||||
| Allergan PlcSHS · shares +15% · price −13.8% | 1.4% | $5.52B | −$767.3M | ||||||||
| Johnson & JohnsonCOM · shares −2.8% · price +12.1% | 1.2% | $4.74B | +$512.3M | ||||||||
| Exxon Mobil CorpCOM · shares −6.7% · price +12.1% | 1.2% | $4.51B | +$488.5M | ||||||||
| Chubb LimitedCOM · shares +3.1% · price +9.7% | 1.1% | $4.43B | +$379.6M | ||||||||
| Jpmorgan Chase & CoCOM · shares −1.7% · price +4.9% | 1.1% | $4.26B | +$200.1M | ||||||||
| Chevron Corp NewCOM · shares +2.3% · price +9.9% | 1.1% | $4.15B | +$365.0M | ||||||||
| Verizon Communications IncCOM · shares −4.0% · price +3.3% | 0.99% | $3.84B | +$121.2M | ||||||||
| Honeywell TechnologiesCOM · shares +4.2% · price +3.8% | 0.96% | $3.73B | +$131.2M | ||||||||
| Marsh & Mclennan Cos IncCOM · shares −0.2% · price +12.6% | 0.91% | $3.53B | +$394.9M | ||||||||
| Comcast Corp NewCL A · shares −1.5% · price +6.7% | 0.90% | $3.48B | +$219.2M | ||||||||
| Eli LillyCOM · shares −1.3% · price +9.4% | 0.88% | $3.41B | +$292.0M | ||||||||
| Pnc Finl Svcs Group IncCOM · shares +0.1% · price −3.8% | 0.88% | $3.39B | −$132.3M | ||||||||
| CiscoCOM · shares −0.7% · price +0.8% | 0.85% | $3.29B | +$25.2M | ||||||||
| IntelCOM · shares −1.0% · price +1.4% | 0.85% | $3.28B | +$44.9M | ||||||||
| AlphabetCAP STK CL A · shares +6.8% · price −7.8% | 0.83% | $3.22B | −$254.3M | ||||||||
| United Parcel Service IncCL B · shares +0.4% · price +2.1% | 0.82% | $3.18B | +$66.2M | ||||||||
| BlackRockCOM · shares −2.0% · price +0.6% | 0.79% | $3.06B | +$17.5M | ||||||||
| Colgate Palmolive CoCOM · shares −1.7% · price +3.6% | 0.76% | $2.95B | +$102.9M | ||||||||
| Coca Cola CoCOM · shares −3.8% · price −2.3% | 0.74% | $2.85B | −$66.6M | ||||||||
| Total · 2,073 positions | 100% | $386.87B | +$10.14B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2016 to Q2 2016: 1,777 stocks held throughout, up $10.14B (+2.9%).
- Bristol Myers Squibb Co+$1.25B+15%
- Medtronic Plc+$869.7M+16%
- Merck & Co Inc+$826.9M+9%
- Unitedhealth Group Inc+$647.6M+10%
- Johnson & Johnson+$512.3M+12%
- Ss&C Technologies Hldgs Inc−$241.1M−56%
- Alphabet−$254.3M−8%
- Apple−$343.8M−12%
- Microsoft−$580.4M−7%
- Allergan Plc−$767.3M−14%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |